Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05933772 · ClinicalTrials.gov registry record · NA

Performance Evaluation of Two Silicone Hydrogel Toric Lens Designs in Habitual Soft Contact Lens Wearers

A NA study, sponsored by CooperVision International Limited (CVIL).

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT05933772: Completed NA study, sponsored by CooperVision International Limited (CVIL).

NCT05933772 is a NA study that has completed, run by CooperVision International Limited (CVIL). The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05933772, a NA study, has completed, sponsored by CooperVision International Limited (CVIL).

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The objective of the study was to compare the clinical performance of two monthly toric silicone hydrogel contact lenses in habitual wearers, when worn for 1-month each.

Primary Outcome

Lens Handling on Removal, using a 0-100 scale (0= very difficult, 100=very easy).

Interventions

  • DEVICE Lens A (comfilcon A toric lens)
  • DEVICE Lens B (lehfilcon A toric lens)

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-08-18
Est. Completion 2023-12-28
Phase NA

What the finished NCT05933772 record still lists

NCT05933772 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Lens A (comfilcon A toric lens) is the first listed.

NCT05933772 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05933772 about?

NCT05933772 is a clinical study titled "Performance Evaluation of Two Silicone Hydrogel Toric Lens Designs in Habitual Soft Contact Lens Wearers". The objective of the study was to compare the clinical performance of two monthly toric silicone hydrogel contact lenses in habitual wearers, when worn for 1-month each.

What is the current status of trial NCT05933772?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2023-08-18. Estimated completion is 2023-12-28.

What interventions are being tested in trial NCT05933772?

The interventions under investigation include: Lens A (comfilcon A toric lens) (DEVICE), Lens B (lehfilcon A toric lens) (DEVICE).

Who is sponsoring clinical trial NCT05933772?

This trial is sponsored by CooperVision International Limited (CVIL), which has 11 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05933772's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05933772, the US trial registry maintained by the National Library of Medicine. NCT05933772 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.